Skip to main content
Gland Pharma Limited logo

Gland Pharma Limited — Investor Relations & Filings

Ticker · GLAND ISIN · INE068V01023 LEI · 335800JJVDY5R6KF5K34 BSE.NS Manufacturing
Open in API
Filings indexed 680 across all filing types
Latest filing 2021-12-08 Regulatory Filings
Country IN India
Listing BSE.NS GLAND

About Gland Pharma Limited

https://glandpharma.com

Gland Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) focused on injectable formulations. The company operates primarily through a business-to-business (B2B) model, providing development and manufacturing services for a diverse range of sterile injectables. Its portfolio encompasses complex generics across various therapeutic areas, including oncology, ophthalmology, anti-infectives, and orthopedics. Gland Pharma maintains a vertically integrated supply chain, ensuring control over critical raw materials and active pharmaceutical ingredients. The company serves a global market, with a significant presence in regulated regions such as the United States, Europe, Canada, and Australia. Its manufacturing facilities adhere to international quality standards and hold approvals from major regulatory bodies. Key strengths include expertise in niche segments like heparin and enoxaparin, alongside a robust pipeline of complex delivery systems.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Gland Pharma has received tentative approval from the US FDA for a pharmaceutical product. It is addressed to stock exchanges and references regulatory disclosure requirements. The content is an announcement of a regulatory milestone and does not contain financial statements, management discussion, or detailed financial data. The document length is 3416 characters, which is relatively short and typical for a press release. There is no indication that this is a full financial report, earnings release, or management report. It is not a voting result, board change, or legal proceeding. The document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit other specific categories.
2021-12-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a letter addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references compliance with SEBI regulations and provides a list of upcoming meetings. There is no financial data, report content, or detailed presentation included. The document is an announcement about meetings rather than a report or transcript of the meetings themselves. Therefore, it fits best under Investor Presentation (IP) as it relates to investor relations activities, specifically scheduling meetings with analysts and investors.
2021-12-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of the schedule of analyst and institutional investor meetings. It references compliance with SEBI regulations and provides dates and types of meetings (tele/video conference and in-person). There is no financial data, no report attached or referenced as being published, and no detailed financial or management discussion. The content is an announcement of upcoming investor meetings, which fits the category of Investor Presentation (IP) as it relates to investor relations activities and presentations to analysts and institutional investors.
2021-12-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a letter addressed to stock exchanges notifying them about the schedule of analyst and institutional investor meetings. It references compliance with SEBI regulations and provides details of an upcoming investor conference call. The document is short (1326 characters) and does not contain any financial data, results, or detailed presentations. It is an announcement of a meeting schedule rather than the meeting materials or transcript itself. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor meetings and presentations, but since it only announces the schedule and does not provide the presentation itself, it is more appropriate to classify it as Regulatory Filings (RNS) which is the fallback for miscellaneous regulatory announcements that do not fit other categories. Given the content and length, confidence is high.
2021-11-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of the schedule of upcoming analyst and institutional investor meetings. It references compliance with SEBI regulations and provides dates and names of institutions for meetings. There is no financial data, report content, or detailed presentation included. The document is an announcement of meetings rather than a report or transcript. Therefore, it fits best under Investor Presentation (IP) as it relates to investor communications and meetings, but since it only schedules meetings and does not contain presentation content, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory disclosure about investor meetings without substantive financial or presentation content.
2021-11-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of upcoming analyst and institutional investor meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The content is an announcement of meetings rather than a financial report, earnings release, or detailed presentation. The document length is short (1241 characters) and does not contain financial data or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-22 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.